Skip to main content

Exicure, Inc.

corporate_fare Company Profile

Exicure, Inc.

XCUR·NASDAQ·Life Sciences·CIK 0001698530

The company, historically an early-stage biotechnology firm, focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, it significantly reduced its workforce, suspended preclinical activities, and halted all research and development. In February 2024, the company received an upfront payment of $500,000 from a licensing agreement for patents related to one of its historical drug candidates, along with a small, one-time payment and an entitlement to modest future royalties. In the second quarter of 2024, it recognized other income of $637,000 from the sale of samples related to the licensed product. In the third quarter of 2024, the company sold its historical biotechnology intellectual property and other assets, including the aforementioned licensing agreement, recognizing other income of $1,500,000. Any future value from these historical assets will primarily come from royalties and license fees under this purchase agreement, though these are uncertain. The company is actively exploring strategic alternatives, including private company acquisitions, raising additional capital, and strategic partnerships. On January 19, 2025, the company acquired all issued and outstanding equity securities of GPCR Therapeutics USA Inc., a California corporation, from GPCR Therapeutics Inc., a Korean corporation.

Exicure, Inc. (NASDAQ:XCUR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 30 items for XCUR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for XCUR spans 10-Q, 8-K, PRE 14A, 4.

Recent high-impact activity:

  • Exicure Q3: $1.2M Cash, Going Concern, Nasdaq Equity Shortfall Before Dec 2 Deadline
  • Exicure Signs Parkinson's Device Deal; Plans 20%-100% NeuroQ Stake Via Share Issuance
  • Exicure Delays Q3 10-Q, Citing Accounting Review of Assets and Liabilities
  • Exicure to Sell GPC-100 Program to GPCRT for ~US$4.8M Cash
  • Exicure to Sell GPC-100 Program to Korea's GPCRT for ~$4.8M Cash

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$0
Net Income
-$4.95M
Diluted EPS
-$0.79
Op. Cash Flow
-$8.55M
Free Cash Flow
-$8.56M
Operating Income
-$4.23M
Cash & Equivalents
$3.75M
Debt / Equity
0.00×
Shares Outstanding
6.37M sh
Source: 10-K · filed 2026-03-25 · accession 0001698530-26-000028

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 52,218 shares in XCUR as of the October 30, 2026 settlement, a 21.7% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 15.6% of XCUR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)52,218 shares as of October 30, 2026
Change vs prior period▲ 21.7%
Days to cover1.00 at avg daily volume of 76,751
Daily short volume (FINRA facilities)15.6% of 18,026 shares on November 20, 2026
5-day average short volume25.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with X →
$0.9905 +1.07% today
52-week range · as of 2026-11-20 $0.777 – $9.48
Market cap
$5.89M
Volume
32.1K (0.4× avg)
3-mo avg 73.2K
Live data · 2026-11-22 05:30 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed XCUR - Latest Insights

XCUR
Nov 20, 2026, 5:13 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.9001
Real-time Price: $0.9905 info
Change: +$0.0904 (+10%) info
Market Cap: $5.892M info
XCUR
Nov 20, 2026, 1:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.920
Real-time Price: $0.9905 info
Change: +$0.0705 (+8%) info
Market Cap: $5.892M info
XCUR
Nov 16, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $0.9905 info
Change: -$0.0795 (-7%) info
Market Cap: $5.892M info
XCUR
Nov 10, 2026, 3:50 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $0.9905 info
Change: -$0.0905 (-8%) info
Market Cap: $5.892M info
XCUR
Nov 10, 2026, 3:50 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $0.9905 info
Change: -$0.0905 (-8%) info
Market Cap: $5.892M info
XCUR
Nov 02, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $0.9905 info
Change: -$0.0695 (-7%) info
Market Cap: $5.892M info
XCUR
Sep 16, 2026, 10:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $0.9905 info
Change: -$0.3145 (-24%) info
Market Cap: $5.892M info
XCUR
Aug 14, 2026, 3:27 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $0.9905 info
Change: -$0.2695 (-21%) info
Market Cap: $5.892M info
XCUR
Jul 17, 2026, 4:39 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.63
Real-time Price: $0.9905 info
Change: -$0.6395 (-39%) info
Market Cap: $5.892M info
XCUR
Jul 17, 2026, 1:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.67
Real-time Price: $0.9905 info
Change: -$0.6745 (-41%) info
Market Cap: $5.892M info
XCUR
Jun 30, 2026, 3:03 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $0.9905 info
Change: -$1.01 (-51%) info
Market Cap: $5.892M info
XCUR
Jun 30, 2026, 2:55 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.03
Real-time Price: $0.9905 info
Change: -$1.04 (-51%) info
Market Cap: $5.892M info
XCUR
May 29, 2026, 2:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.16
Real-time Price: $0.9905 info
Change: -$2.17 (-69%) info
Market Cap: $5.892M info
XCUR
Apr 22, 2026, 7:57 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.98
Real-time Price: $0.9905 info
Change: -$2.99 (-75%) info
Market Cap: $5.892M info
XCUR
Apr 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.78
Real-time Price: $0.9905 info
Change: -$2.79 (-74%) info
Market Cap: $5.892M info
XCUR
Apr 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.19
Real-time Price: $0.9905 info
Change: -$3.20 (-76%) info
Market Cap: $5.892M info
XCUR
Mar 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.00
Real-time Price: $0.9905 info
Change: -$3.01 (-75%) info
Market Cap: $5.892M info
XCUR
Mar 27, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.00
Real-time Price: $0.9905 info
Change: -$3.01 (-75%) info
Market Cap: $5.892M info
XCUR
Mar 25, 2026, 4:42 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $4.61
Real-time Price: $0.9905 info
Change: -$3.62 (-79%) info
Market Cap: $5.892M info
XCUR
Mar 25, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.61
Real-time Price: $0.9905 info
Change: -$3.62 (-79%) info
Market Cap: $5.892M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets